Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription regulator protein BACH1, also known as BTB and CNC homology 1, is a basic leucine zipper (bZIP) transcription factor that plays a critical role in regulating the cellular response to oxidative stress and heme homeostasis (UniProt P62701). It primarily functions as a transcriptional repressor by binding to Maf recognition elements (MAREs) in the promoters of target genes, such as heme oxygenase-1 (HMOX1), thereby competing with the antioxidant activator Nrf2. BACH1 is highly sensitive to intracellular heme levels; heme binding to its CP motifs triggers its dissociation from DNA and subsequent proteasomal degradation, allowing for the induction of antioxidant and detoxifying enzymes. In the context of disease, BACH1 is frequently overexpressed in various cancers, where it promotes epithelial-mesenchymal transition (EMT), metabolic reprogramming, and metastasis, particularly in triple-negative breast cancer and lung adenocarcinoma (PMID: 31243371, 31243372). Beyond oncology, its role in suppressing antioxidant defenses makes it a target for treating cardiovascular and neurodegenerative diseases characterized by oxidative damage. Therapeutic strategies focusing on BACH1 include small-molecule inhibitors that induce its degradation or block its DNA-binding activity, aiming to restore redox balance or inhibit tumor progression (PMID: 30559440).
BACH1 inhibitors typically function by inducing the proteasomal degradation of the BACH1 protein or by preventing its binding to Antioxidant Response Elements (AREs), thereby derepressing the expression of cytoprotective genes like HMOX1 and inhibiting pro-metastatic pathways.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription regulator protein BACH1 (BACH1).